Stock Movers

Estee Lauder Gains, Imax Jumps, Denali Therapeutics Slides After Parkinson’s Drug Trial Failure

2 min · 22. maj 2026
episode Estee Lauder Gains, Imax Jumps, Denali Therapeutics Slides After Parkinson’s Drug Trial Failure cover

Description

On this episode of Stock Movers: - Estee Lauder (EL) shares gain. The US beauty company and Spanish firm Puig confirmed talks about a potential business combination have ended. Analysts cite several reasons for the positive reaction to the termination of talks, including “aversion to large deals,” integration risk/potential dilution to shareholders, as well as distraction to core business and its Beauty Reimagined strategic plan. Some analysts see better M&A opportunities in fragrance, or in masstige/mass segments. - Imax (IMAX) shares jump. The Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. The sale process is in early stages and may not result in a deal, the report states, citing people familiar with the situation - Denali Therapeutics (DNLI) shares slide. The drug developer said a mid-stage study of an experimental therapy for Parkinson’s disease, with partner Biogen, did not meet its primary or secondary endpoints. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Comments

0

Be the first to comment

Sign up now and become a member of the Stock Movers community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

300 episodes

episode Broadcom Sinks After Disappointing Outlook; CrowdStrike Results Fail to Wow; Petco Shares Drop artwork

Broadcom Sinks After Disappointing Outlook; CrowdStrike Results Fail to Wow; Petco Shares Drop

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Broadcom (AVGO) shares fall after the chipmaker gave an outlook that was seen as underwhelming, given the industry’s AI-related demand. Analysts note that AI sales and margins for the current quarter are weaker than expected. - CrowdStrike (CRWD) shares are down after the security software company reported first-quarter results beat, which wasn’t strong enough to lift the stock that has more than doubled from a March low. - Petco (WOOF) shares tumble after the pet health and wellness company’s second-quarter adjusted Ebitda forecast came in below the average analyst estimate. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

4. juni 20264 min
episode Remy Cointreau Rises, Abivax Gains, Universal Dips artwork

Remy Cointreau Rises, Abivax Gains, Universal Dips

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Remy Cointreau posted slightly better-than-expected annual profit as strong growth in the Americas helped the Cognac maker stem losses from tepid demand in its critical European and Chinese markets. - Abivax shares climb as much as 14% in Paris, extending a rally after the stock plunged due to cancer cases in a crucial clinical trial. The market reaction to the cases in the French biotech company’s late-stage trial results for its experimental ulcerative colitis drug are “overdone,” according to Stifel analysts. - Universal Music Group shares fell after Bill Ackman sold his €1.42 billion ($1.65 billion) stake in the Amsterdam-listed company just days after it rejected a takeover bid by the hedge fund billionaire. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

4. juni 20264 min
episode Broadcom Slides on Disappointing AI Outlook, CrowdStrike Falls, Petco Drops artwork

Broadcom Slides on Disappointing AI Outlook, CrowdStrike Falls, Petco Drops

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Broadcom (AVGO) shares fell in extended trading after the company delivered a disappointing forecast for artificial intelligence chip revenue, signaling it’s efforts to gain ground in the burgeoning industry are going more slowly than anticipated. AI semiconductor revenue will be $16 billion in the fiscal third quarter, which runs through July, the company said in a statement Wednesday. Analysts predicted $17.2 billion on average, according to data compiled by Bloomberg. - CrowdStrike (CRWD) shares fell in extended trading after the security software company reported its first-quarter results and gave an outlook. While the results beat expectations and the full-year forecast was raised on key metrics, the report wasn’t strong enough to extend the recent strength in the stock. - Petco (WOOF) saw its shares tumble post-market after the pet health and wellness company’s second-quarter adjusted Ebitda forecast came in below the average analyst estimate. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Yesterday3 min
episode Closing Bell: MiniMed Surges, Ulta Slips, CrowdStrike Beats Estimates artwork

Closing Bell: MiniMed Surges, Ulta Slips, CrowdStrike Beats Estimates

On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. - MiniMed (MMED) shares jump as much as 20%, most intraday on record, after the diabetes device maker reported fourth-quarter net sales and a CGM attachment rate that surpassed expectations. MiniMed also said it plans to commercialize dual glucose-ketone sensors with Abbott. - Ulta (UTLA) shares traded lower after analysts noted that guidance for the retailer suggests a gloomier outlook for the back half of the year than initially anticipated. - CrowdStrike (CRWD) delivered earnings after the bell, boosting adjusted earnings per share for the second quarter. Shares traded lower afterhours. See omnystudio.com/listener [https://omnystudio.com/listener] for privacy information.

Yesterday6 min